Stewart A. Factor

28.7k total citations · 2 hit papers
275 papers, 14.0k citations indexed

About

Stewart A. Factor is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stewart A. Factor has authored 275 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Neurology, 71 papers in Psychiatry and Mental health and 53 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stewart A. Factor's work include Parkinson's Disease Mechanisms and Treatments (177 papers), Neurological disorders and treatments (138 papers) and Botulinum Toxin and Related Neurological Disorders (62 papers). Stewart A. Factor is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (177 papers), Neurological disorders and treatments (138 papers) and Botulinum Toxin and Related Neurological Disorders (62 papers). Stewart A. Factor collaborates with scholars based in United States, Canada and Israel. Stewart A. Factor's co-authors include Eric Molho, William J. Weiner, Cyrus P. Zabetian, Haydeh Payami, Joseph H. Friedman, Gerald D. Podskalny, Diane Brown, Juan Sanchez‐Ramos, Robert A. Hauser and Erin M. Hill‐Burns and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Stewart A. Factor

270 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

2017 653 citations Stewart A. Factor, Eric Molho et al. Movement Disorders profile →
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

2010 584 citations Cyrus P. Zabetian, Jennifer S. Montimurro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stewart A. Factor United States	65	10.3k	3.6k	2.5k	1.9k	1.7k	275	14.0k
Kenneth Marek United States	52	9.9k 1.0×	3.5k 1.0×	1.2k 0.5×	1.8k 0.9×	1.4k 0.9×	189	13.5k
Gianni Pezzoli Italy	60	8.0k 0.8×	3.0k 0.8×	1.2k 0.5×	2.6k 1.3×	1.3k 0.8×	285	12.8k
Robert A. Hauser United States	74	13.7k 1.3×	6.8k 1.9×	1.8k 0.7×	3.0k 1.6×	1.4k 0.8×	358	18.9k
Ubaldo Bonuccelli Italy	56	6.6k 0.6×	2.5k 0.7×	2.1k 0.8×	1.5k 0.8×	1.2k 0.7×	365	11.1k
Connie Marras Canada	54	6.9k 0.7×	1.9k 0.5×	1.7k 0.7×	1.4k 0.8×	1.1k 0.7×	237	10.5k
Fabrizio Stocchi Italy	60	10.1k 1.0×	3.2k 0.9×	1.4k 0.5×	1.1k 0.6×	904 0.5×	319	12.6k
Jaime Kulisevsky Spain	55	9.4k 0.9×	2.8k 0.8×	3.3k 1.3×	964 0.5×	1.5k 0.9×	321	13.8k
Angelo Antonini Italy	78	15.8k 1.5×	5.4k 1.5×	2.0k 0.8×	1.6k 0.8×	1.8k 1.1×	529	21.0k
Piu Chan China	51	7.6k 0.7×	2.7k 0.8×	1.1k 0.4×	2.3k 1.2×	1.4k 0.8×	189	13.5k
S. E. Daniel United Kingdom	29	11.0k 1.1×	3.4k 0.9×	1.5k 0.6×	1.8k 0.9×	2.1k 1.3×	44	13.7k

Countries citing papers authored by Stewart A. Factor

Since Specialization

Citations

This map shows the geographic impact of Stewart A. Factor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart A. Factor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart A. Factor more than expected).

Fields of papers citing papers by Stewart A. Factor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stewart A. Factor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart A. Factor. The network helps show where Stewart A. Factor may publish in the future.

Co-authorship network of co-authors of Stewart A. Factor

This figure shows the co-authorship network connecting the top 25 collaborators of Stewart A. Factor. A scholar is included among the top collaborators of Stewart A. Factor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stewart A. Factor. Stewart A. Factor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilat, Moran, Jorik Nonnekes, Stewart A. Factor, et al.. (2026). An updated definition of freezing of gait. Nature Reviews Neurology. 22(3). 172–181.

Fasano, Alfonso, Moran Gilat, Stewart A. Factor, et al.. (2025). Management of freezing of gait — mechanism-based practical recommendations. Nature Reviews Neurology. 21(6). 327–344. 4 indexed citations

Higginbotham, Lenora, et al.. (2024). Prevalence and clinical features of cervical dystonia in Parkinson's disease. Parkinsonism & Related Disorders. 127. 107114–107114.

Tripathi, Richa, Stewart A. Factor, Hyeokhyen Kwon, et al.. (2024). Development of a Tremor Detection Algorithm for Use in an Academic Movement Disorders Center. Sensors. 24(15). 4960–4960. 1 indexed citations

Kassubek, Jan, Stewart A. Factor, Johannes Schwarz, et al.. (2024). Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson’s disease complicated by OFF episodes: a phase 3, open-label study. Journal of Neurology. 271(6). 3554–3570. 4 indexed citations

Block, Cady, Benjamin B. Risk, David W. Loring, et al.. (2023). Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case‐Control Study. Movement Disorders Clinical Practice. 10(3). 382–391. 9 indexed citations

Kwon, Hyeokhyen, et al.. (2023). An Explainable Spatial-Temporal Graphical Convolutional Network to Score Freezing of Gait in Parkinsonian Patients. Sensors. 23(4). 1766–1766. 16 indexed citations

McKay, J. Lucas, et al.. (2022). Quantitative motion analysis and clinical characteristics of Holmes tremor as compared to other tremor types (S32.008). Neurology. 98(18_supplement). 3 indexed citations

Hatcher-Martin, Jaime M., J. Lucas McKay, Barbara Sommerfeld, et al.. (2021). Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis. npj Parkinson s Disease. 7(1). 105–105. 17 indexed citations

10.

Factor, Stewart A.. (2020). Management of Tardive Syndrome: Medications and Surgical Treatments. Neurotherapeutics. 17(4). 1694–1712. 15 indexed citations

11.

Higginbotham, Lenora, Lingyan Ping, Eric B. Dammer, et al.. (2020). Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease. Science Advances. 6(43). 194 indexed citations

12.

Espay, Alberto J., James C. Norton, Bruce Coate, et al.. (2018). Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications. Movement Disorders. 33(11). 1769–1776. 37 indexed citations

13.

Tripathi, Richa, et al.. (2018). Parkinson Disease from long term drug abuse: Meta-analysis of amphetamine/methamphetamine and Parkinson Disease (P6.079). Neurology. 90(15_supplement). 4 indexed citations

14.

Fernandez, Hubert H., David Stamler, Mat D. Davis, et al.. (2018). Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study (P4.075). Neurology. 90(15_supplement). 1 indexed citations

15.

Factor, Stewart A., William M. McDonald, & Felicia C. Goldstein. (2017). The role of neurotransmitters in the development of Parkinson's disease‐related psychosis. European Journal of Neurology. 24(10). 1244–1254. 54 indexed citations

16.

Seegal, Richard F., Edward F. Fitzgerald, Robert J. McCaffrey, et al.. (2013). Tibial Bone Lead, but Not Serum Polychlorinated Biphenyl, Concentrations Are Associated With Neurocognitive Deficits in Former Capacitor Workers. Journal of Occupational and Environmental Medicine. 55(5). 552–562. 5 indexed citations

17.

Pahwa, Rajesh, Stewart A. Factor, Kelly E. Lyons, et al.. (2006). Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]. Neurology. 66(7). 983–995. 353 indexed citations

18.

Kay, Denise M., T. Bird, Cyrus P. Zabetian, et al.. (2006). Validity and Utility of a LRRK2 G2019S Mutation Test for the Diagnosis of Parkinson's Disease. Genetic Testing. 10(3). 221–227. 17 indexed citations

19.

Factor, Stewart A., Diane Brown, & Eric Molho. (2000). Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease. Movement Disorders. 15(1). 167–169. 38 indexed citations

20.

Molho, Eric, Paul J. Feustel, & Stewart A. Factor. (1998). Clinical comparison of tardive and idiopathic cervical dystonia. Movement Disorders. 13(3). 486–489. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact